Palvella Therapeutics, Inc 10-K for FY2019

Headline figures

Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$46.28M

up 59.0% from $29.1M a year earlier

Net loss

$25.47M

compared with a net loss of $26.75M a year earlier